Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.54 |
| ▸ | ERN1 | O75460 | 6/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | AHR | P35869 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | TTR | P02766 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3134002 | 0.94 | TDP1 (0.59) | TDP1ERN1ALDH1A1MEN1KMT2A | |
| SCHEMBL26908511 | 0.91 | TDP1 (0.56) | TDP1ERN1ALDH1A1MAPK1AHR | |
| SCHEMBL1953389 | 0.88 | TDP1 (0.52) | TDP1ERN1ALDH1A1MAPK1AHR | |
| SCHEMBL29556939 | 0.88 | TDP1 (0.52) | TDP1ERN1ALDH1A1MAPK1AHR | |
| SCHEMBL30207763 | 0.81 | TDP1 (0.48) | TDP1ERN1ALDH1A1MEN1KMT2A | |
| SCHEMBL1808858 | 0.81 | TDP1 (0.48) | TDP1ERN1ALDH1A1MEN1KMT2A | |
| SCHEMBL8672712 | 0.81 | TDP1 (0.48) | TDP1ERN1ALDH1A1MEN1KMT2A | |
| SCHEMBL7892856 | 0.79 | GAA (0.50) | TDP1ERN1ALDH1A1MAPK1MEN1 | |
| SCHEMBL3377931 | 0.79 | ERN1 (0.54) | TDP1ERN1ALDH1A1MEN1KMT2A | |
| SCHEMBL6187165 | 0.79 | TDP1 (0.46) | TDP1ERN1ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116178121-A | Preparation method of 2,4, 5-trifluoro-benzaldehyde | 浙江巍华新材料股份有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-111499506-A | Green production process of 2, 4-dichloro-5-fluorobenzoyl chloride | 浙江本立科技股份有限公司 | 2020-08-07 | — | — | CN | claimed |
| US-9234087-B2 | Preparation for initiating radical reactions | UNITED INITIATORS GMBH & CO. KG (DE) | 2016-01-12 | — | — | US | claimed |
| EP-2288652-B1 | PREPARATION FOR INITIATING RADICAL REACTIONS | UNITED INITIATORS GMBH & CO KG (DE) | 2012-09-19 | — | — | EP | claimed |
| EP-2130858-B1 | Preparations to initiate radical reactions | UNITED INITIATORS GMBH & CO KG (DE) | 2012-07-25 | — | — | EP | claimed |
| US-20110272628-A1 | Preparation For Initiating Radical Reactions | UNITED INITIATORS GMBH (DE) | 2011-11-10 | — | — | US | claimed |
| EP-2288652-A1 | PREPARATION FOR INITIATING RADICAL REACTIONS | United Initiators GmbH & Co. KG (DE) | 2011-03-02 | — | — | EP | claimed |
| WO-2009146916-A1 | PREPARATION FOR INITIATING RADICAL REACTIONS | UNITED INITIATORS GMBH & CO. KG (DE) | 2009-12-10 | — | — | WO | claimed |
| EP-2130858-A1 | Preparations to initiate radical reactions | Degussa Initiators GmbH & Co. KG (DE) | 2009-12-09 | — | — | EP | claimed |
| CN-116178121-A | Preparation method of 2,4, 5-trifluoro-benzaldehyde | 浙江巍华新材料股份有限公司 | 2023-05-30 | — | — | CN | disclosed |
| CN-116178121-A | Preparation method of 2,4, 5-trifluoro-benzaldehyde | 浙江巍华新材料股份有限公司 | 2023-05-30 | — | — | CN | disclosed |
| CN-107820518-B | Methods for selecting phosphatase selective inhibitors and non-selective phosphatase inhibitors | 英国研究与创新署 | 2023-04-21 | — | — | CN | disclosed |
| US-11547747-B2 | Treatment and detection of infection and disease associated with different fungal pathogens | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2023-01-10 | — | — | US | disclosed |
| US-20220401533-A1 | TREATMENT AND PROTECTION AGAINST ASPERGILLUS INFECTION AND ASPERGILLOSIS DISEASE | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2022-12-22 | — | — | US | disclosed |
| EP-0041675-A2 | 4-Halogen-5-(trichloromethyl-phenyl)-oxazole derivatives, process for preparing them and radiation-sensitive compositions containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-12-16 | — | — | EP | disclosed |
| US-4205193-A | CATALYST FROM ALUMINUM AND TITANIUM COMPOUND, ORGANOOXYGEN COMPOUND AND ORGANOSULFUR CONTAINING COMPOUND | MITSUBISHI PETROCHEMICAL COMPANY LIMITED (JP) | 1980-05-27 | — | — | US | disclosed |
| US-4018926-A | Alkyl 4-[o-(substituted methyleneamino)-phenyl]-3-thioallophanate miticides and fungicides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-04-19 | — | — | US | disclosed |
| US-4011213-A | FUNGICIDES, MITE OVICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-03-08 | — | — | US | disclosed |
| US-3984438-A | INSECTICIDES AND FIRE RETARDANTS | HOOKER CHEMICALS & PLASTICS CORPORATION (US) | 1976-10-05 | — | — | US | disclosed |
| US-3958007-A | FUNGICIDES, MITE OVICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11547747-B2 | Treatment and detection of infection and disease associated with different fungal pathogens | KLK3, KLKB1, KLK5 | TDP1 3201/4885ERN1 1053/4885ALDH1A1 4865/4885 |
| US-20220401533-A1 | TREATMENT AND PROTECTION AGAINST ASPERGILLUS INFECTION AND ASPERGILLOSIS DISEASE | KLKB1, MASP2, ANTXR2 | TDP1 3896/4885ERN1 1254/4885ALDH1A1 4737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.